NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Science&Humans

Science&Humans

Private
TorontoHealthcare & Life Scienceshttps://www.scienceandhumans.com/

Last Round

Series A

Jan 21, 2026

Total Funding Raised

$16.91M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Science&Humans is a healthtech company that operates a telemedicine platform offering personalized treatment for hormone health imbalances.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement, D2C Brands, Subscription Commerce

Business Model

B2C

Customer Profile

Subscription SaaS, Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

telemedicinehormone healthdigital healthvirtual clinictelehealthmenopause careweight managementat-home diagnosticsprescription deliverymetabolic healthemployee benefitsdirect-to-consumerD2CB2B2Cfemtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Science&Humans Comps

Public and private peers based on sector, stage, and business model.

Science&Humans comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Science&Humans Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 21, 2026
DebtDec 1, 2025
Series ADec 1, 2025
View all Funding Rounds

Key People

Founding team and executive leadership

Wendy Yu

CFO

Executive Team

Science&Humans Investors

Notable investors and investment history

Science&Humans investors
InvestorRounds
BDC CapitalDebt
CIBC Innovation BankingSeries A, Debt
WELL VenturesSeries A
Pender VenturesSeries A
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    Michele Romanow named brand ambassador for 2026.

  • Nov 2, 2025

    Serves over 50,000 customers as Canada's largest hormone health platform.

View all signals

Science&Humans Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Science&Humans Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Science&Humans's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto
Employee Range84
Year Founded2018
Last FundingJan 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.